Exploring the Potential of Thymoquinone-Stabilized Selenium Nanoparticles: In HEC1B Endometrial Cancer Cells Revealing Enhanced Anticancer Efficacy.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
24 Oct 2023
24 Oct 2023
Historique:
received:
15
08
2023
accepted:
02
10
2023
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
epublish
Résumé
The aim of this research is to examine the potential anticancer properties of thymoquinone (TQ)-encapsulated selenium nanoparticles (TQ-SeNPs) in HEC1B endometrial carcinoma cells. TQ-SeNPs were synthesized, and their size, morphology, and elemental analysis were characterized. Morphological changes were examined by using scanning electron microscopy (SEM). The cytotoxicity and viability of nanothymoquinone were assessed by the XTT (2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2
Identifiants
pubmed: 37901525
doi: 10.1021/acsomega.3c06028
pmc: PMC10601430
doi:
Types de publication
Journal Article
Langues
eng
Pagination
39822-39829Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Mutat Res. 2011 Jan 10;706(1-2):28-35
pubmed: 21040738
Front Pharmacol. 2017 Sep 21;8:656
pubmed: 28983249
Chem Biol Interact. 2018 Nov 1;295:119-132
pubmed: 29421519
Invest New Drugs. 2012 Dec;30(6):2121-31
pubmed: 22170088
J Ginseng Res. 2021 Jan;45(1):22-31
pubmed: 33437153
Cell Physiol Biochem. 2017;41(3):933-946
pubmed: 28222438
Public Health Nutr. 2001 Apr;4(2B):593-9
pubmed: 11683552
Iran J Pharm Res. 2015 Spring;14(2):539-46
pubmed: 25901162
Int J Biol Macromol. 2020 Jun 1;152:605-615
pubmed: 32087224
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):443-449
pubmed: 29424901
Curr Pharm Biotechnol. 2018;19(12):934-945
pubmed: 30421672
Front Oncol. 2019 Jul 03;9:599
pubmed: 31334120
ACS Omega. 2023 Sep 04;8(37):33554-33563
pubmed: 37744806
Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2680-8
pubmed: 27383323
Int J Biol Macromol. 2019 May 15;129:818-826
pubmed: 30776437
Am J Cancer Res. 2011;1(1):43-61
pubmed: 21969218
J Nutr Biochem. 2008 Jan;19(1):1-7
pubmed: 17588734
Int J Nanomedicine. 2020 Oct 20;15:8059-8074
pubmed: 33116518
Cells. 2020 Oct 16;9(10):
pubmed: 33081387
Drug Dev Ind Pharm. 2021 Dec;47(12):1943-1951
pubmed: 35510706
Nanoscale. 2020 Jul 16;12(27):14494-14503
pubmed: 32614349
J Ginseng Res. 2017 Oct;41(4):435-443
pubmed: 29021688
Molecules. 2022 Aug 26;27(17):
pubmed: 36080264
Oncol Rep. 2013 Feb;29(2):571-8
pubmed: 23232982
ACS Omega. 2022 Nov 17;7(48):44438-44447
pubmed: 36506173
Comb Chem High Throughput Screen. 2021;24(10):1644-1653
pubmed: 33115388
Food Chem. 2023 Feb 15;402:134470
pubmed: 36303383
Asian Pac J Cancer Prev. 2015;16(11):4571-6
pubmed: 26107205
Nutrition. 2017 Jan;33:83-90
pubmed: 27356860
Proc Nutr Soc. 2005 Nov;64(4):527-42
pubmed: 16313696
Langmuir. 2012 Jan 17;28(2):1562-8
pubmed: 22168477
ACS Omega. 2022 Mar 15;7(12):10718-10728
pubmed: 35382308
Phytother Res. 2023 Feb;37(2):563-577
pubmed: 36184899
J Healthc Eng. 2022 Mar 2;2022:7052066
pubmed: 35281533
ACS Omega. 2022 Feb 18;7(8):7370-7379
pubmed: 35252727
J Cell Physiol. 2019 Sep;234(9):14951-14965
pubmed: 30811039
Eur J Pharm Sci. 2017 Nov 15;109:525-532
pubmed: 28890201
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2015;50(2):119-24
pubmed: 25560257
Mol Biol Rep. 2011 Feb;38(2):865-72
pubmed: 20464500
ACS Omega. 2021 Apr 22;6(17):11466-11473
pubmed: 34056302
Mutat Res. 2014 Oct;768:22-34
pubmed: 25847385
Biomed Pharmacother. 2019 Jul;115:108783
pubmed: 31060003
Int J Nanomedicine. 2019 Apr 10;14:2557-2571
pubmed: 31118605
Biomed Pharmacother. 2019 Mar;111:802-812
pubmed: 30616079
Int J Mol Sci. 2022 Sep 06;23(18):
pubmed: 36142148
Front Mol Neurosci. 2011 Dec 02;4:51
pubmed: 22144946
J BUON. 2020 Sep-Oct;25(5):2271-2278
pubmed: 33277845
Biochim Biophys Acta. 2009 Nov;1790(11):1478-85
pubmed: 19268692